Gland Pharma

Quarterly
Consolidated
ParticularsJun '25Sep '25Dec '25Mar '26Jun '26
Revenue1,5631,5711,7591,8541,862
Expenses1,2501,2871,3721,3481,427
EBITDA425.29398.05498.05624.49550.60
Operating Profit324.24291.74366.06515.83439.34
Profit Before Tax312.74283.91362.13505.80434.98
Net Profit215.48183.68261.48366.68316.96
Financial Ratios
Operating Profit Margin28.25%26.77%27.94%35.83%30.58%
Net Profit Margin14.31%12.35%16.43%21.04%17.61%
Earning Per Share (Diluted)13.0811.1515.8722.2319.22
Dividends Per Share0.000.000.000.000.00